ADMA icon

ADMA

Lightning icon

9.83 USD

-1.33%

Today

-3.12%

1D

Market is closed

Sun

Closed

Mon

4:30 PM ~ 11:00 PM

Tue

4:30 PM ~ 11:00 PM

Wed

4:30 PM ~ 11:00 PM

Thu

4:30 PM ~ 11:00 PM

Fri

4:30 PM ~ 11:00 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

ADMA Biologics Inc. Leveraged

Currency

USD

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0191%

Overnight Fees Sell

0.0024%

Market Cap

2.19B

Avg Daily Volume

15.66M

52 Week High

25.67 USD

52 Week Low

7.21 USD

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01910%$(0.191)
SELLS0.00240%$0.024

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Top News

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?

tradingview.com

1w ago

No Image

Alcoa

-0.55%

ADMA.Biologics

-3.12%

Adient

-1.17%

Alaska_Air

-1.01%

Autoliv

+0.24%

Apollo

-2.49%

Butterfly_Network

-0.97%

BiogenIDEC

-2.24%

BostonSc

+0.70%

Blackstone

-1.66%

Coeur

+2.59%

Century.Aluminum

+1.02%

Carlyle_Group

-1.79%

ColgatePal

-0.52%

CrowdStrike

-4.36%

Chevron

-0.53%

Devon

+0.23%

Expedia

-1.01%

Flextronic

+2.34%

GM.Motors

+0.53%

Group1Auto

+0.01%

Hecla.Mining

+0.73%

RobinHood

-1.55%

Insmed

-3.03%

KKR&Co

-1.65%

Meta

+0.08%

NewmontM

+2.35%

Novavax

-5.52%

Occidental

+0.00%

ProPetro

+1.47%

Quanta

+0.66%

Ultragenyx

-2.44%

SoFiTech

-0.12%

Spire

-0.20%

Seagate

+0.14%

Sysco

-3.15%

UnitedTherapeutics

-0.48%

ExxonMobil

-1.24%

BUZZ-U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM

reuters.com

1w ago

No Image

Alcoa

-0.55%

ADMA.Biologics

-3.12%

Adient

-1.17%

Alaska_Air

-1.01%

Autoliv

+0.24%

Butterfly_Network

-0.97%

BiogenIDEC

-2.24%

BostonSc

+0.70%

Coeur

+2.59%

Century.Aluminum

+1.02%

ColgatePal

-0.52%

CrowdStrike

-4.36%

Chevron

-0.53%

Devon

+0.23%

Expedia

-1.01%

GM.Motors

+0.53%

Group1Auto

+0.01%

Hecla.Mining

+0.73%

Insmed

-3.03%

Meta

+0.08%

NewmontM

+2.35%

Novavax

-5.52%

Occidental

+0.00%

Quanta

+0.66%

Ultragenyx

-2.44%

Spire

-0.20%

Seagate

+0.14%

Sysco

-3.15%

UnitedTherapeutics

-0.48%

ExxonMobil

-1.24%

BUZZ-U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike

reuters.com

1w ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.


Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.


What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.


What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.